Myriel, Inc.

Saint Paul, MN

UEI
C1TUWLJ8CW17
CAGE
Not on record
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
  • Asian-Pacific American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
1000 Westgate Dr #9150e, St Paul, MN 55114, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Prodrugs of potent and selective protease inhibitors as tauopathy therapeutics R41NS134497 National Institute of Neurological Disorders and Stroke (NIH) $1,049,976

Quick answers

Is Myriel, Inc. registered in SAM.gov?

Yes. Myriel, Inc.'s SAM.gov registration is active through April 2, 2027.

What is Myriel, Inc.'s most recent federal award?

Myriel, Inc.'s most recent federal grant award is Prodrugs of potent and selective protease inhibitors as tauopathy therapeutics (R41NS134497), from National Institute of Neurological Disorders and Stroke (NIH), on September 20, 2023.

On GovTribe

See Myriel, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login